Press Releases

Date	Title	PDF Version
Jun 03, 2009	Alexion to Present at Investor Conferences
May 29, 2009	New Study Results Verify That PNH Cells Are Found in Majority of Patients with Bone Marrow Failure Syndromes
May 28, 2009	Researchers to Report on the Investigational Use of Alexion's Soliris(R) (Eculizumab) to Prevent Antibody-Mediated Rejection in High-Risk Kidney Transplant Patients
Apr 23, 2009	Alexion Reports First Quarter 2009 Results
Apr 09, 2009	Alexion Pharmaceuticals to Report First Quarter 2009 Results on April 23, 2009
Apr 01, 2009	Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Mar 25, 2009	Alexion to Present at the 4th Annual Citi Biotech Day
Mar 11, 2009	Alexion to Present at the Cowen and Company 29th Annual Health Care Conference
Feb 27, 2009	Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day
Feb 25, 2009	Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Australia for All Patients with PNH

Search